NCT01870674View on ClinicalTrials.gov

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Healthy

Interventions

DRUG

YH12852

DRUG

Prucalopride

DRUG

Placebo

Trial Locations (1)

614-735

Inje Busan Paik hospital, Busan

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT01870674 - Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects | Biotech Hunter | Biotech Hunter